Adjuvant chemotherapy compared with observation in patients with T2aN0 stage IB lung adenocarcinoma

INTRODUCTION: For patients with T2aN0 stage IB lung adenocarcinoma, benefits of adjuvant chemotherapy remain controversial. Here, we aimed to evaluate such benefits. METHODS: This retrospective cohort study was conducted on the database of the National Taiwan Cancer Registry. We analyzed patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Po-Hsin, Chiang, Chun-Ju, Tseng, Jeng-Sen, Zheng, Zhe-Rong, Chen, Kun-Chieh, Chu, Cheng-Hsiang, Huang, Yen-Hsiang, Hsu, Kuo-Hsuan, Lee, Wen-Chung, Yang, Tsung-Ying, Liu, Tsang-Wu, Hsia, Jiun-Yi, Chang, Gee-Chen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011699/
https://www.ncbi.nlm.nih.gov/pubmed/36925928
http://dx.doi.org/10.3389/fonc.2023.1096683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10011699/
https://www.ncbi.nlm.nih.gov/pubmed/36925928
http://dx.doi.org/10.3389/fonc.2023.1096683

Ejemplares similares